1292317-54-4Relevant academic research and scientific papers
TBK/IKK INHIBITOR COMPOUNDS AND USES THEREOF
-
Paragraph 0247; 0249, (2017/01/23)
The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as TBK/IKKε inhibitors.
TANK-BINDING KINASE INHIBITOR COMPOUNDS
-
Paragraph 0170; 0172; 0173, (2016/05/02)
Compounds having the following formula (I) and methods of their use and preparation are disclosed:
TANK-BINDING KINASE INHIBITOR COMPOUNDS
-
Page/Page column 63-64, (2015/12/24)
Compounds having the following formula (I) and methods of their use and preparation are disclosed:
COMPOUNDS, COMPOSITIONS, AND THERAPEUTIC USES THEREOF
-
Paragraph 0210, (2014/01/17)
The invention relates to compounds, pharmaceutical compositions and medicaments comprising such compounds, and the use of these compounds, compositions, and medicaments in methods of treating a variety of diseases and disorders.
BENZONITRILE DERIVATIVES AS KINASE INHIBITORS
-
Paragraph 0207-0208, (2014/08/19)
Compounds of the formula I, in which R1, R2, X and Y have the meanings indicated in Claim 1, are inhibitors of TBK1 and IKKε and can be employed, inter alia, for the treatment of cancer and inflammatory diseases.
FURO [3, 2 - B] - AND THIENO [3, 2 - B] PYRIDINE DERIVATIVES AS TBK1 AND IKK INHIBITORS
-
Page/Page column 58; 59, (2013/08/28)
Compounds of the formula (I) in which R1, R2 and X have the meanings indicated in Claim 1, are inhibitors of TBK1 and ΙΚΚε and can be employed, inter alia, for the treatment of cancer and inflammatory diseases.
COMPOSITIONS AND THERAPEUTIC USES OF IKK-RELATED KINASE EPSILON AND TANKBINDING KINASE 1 INHIBITORS
-
, (2012/11/06)
The invention relates to compounds, pharmaceutical compositions and medicaments comprising such compounds, and the use of these compounds, compositions, and medicaments in methods of treating diseases and disorders.
AMINO - PYRIMIDINE COMPOUNDS AS INHIBITORS OF TBK1 AND/OR IKK EPSILON
-
, (2011/05/05)
The invention relates to certain aminopyrimidine compounds which inhibit TBK1 and/or IKK epsilon and which may therefore find application in treating inflammation, cancer, septic shock and/or Primary open Angle Glaucoma (POAG).
